Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

141%Other

1.50.890%6.24.538%Total International29.323.326%102.572.641%Total Product Sales$  89.7$  76.917%$  321.5$  265.521%


  • During the fourth quarter of 2012, Cepheid placed a total of 153 GeneXpert systems in its commercial Clinical business.  Additionally, the Company placed a total of 68 GeneXpert systems as part of its High Burden Developing Country (HBDC) program.  For the year ended December 31, 2012, Cepheid placed a total of 523 GeneXpert systems in its commercial Clinical business and an additional 506 GeneXpert systems as part of its HBDC program.  As of December 31, 2012, a cumulative total of 3,835 GeneXpert systems have been placed worldwide.
  • Cash and cash equivalents were $95.8 million as of December 31, 2012.
  • DSO was 43 days.
  • Business OutlookFor the fiscal year ending December 31, 2013, the Company expects:

  • Total revenue to be in the range of $375 to $385 million;
  • Net income to range from a net loss of $(0.05) to net income of $0.01 per share; 
  • Non-GAAP net income in the range of $0.41 to $0.46 per share. 
  • Expected non-GAAP net income excludes approximately $29 million related to stock compensation expense and approximately $4 million related to the amortization of acquired intangibles.  The fully diluted share count for the year is expected to be approximately 72 million, except in the event of a GAAP loss where the share count would be approximately 67 million shares.

    The following table reconciles net income (loss) per share to the non-GAAP net income per share range:Guidance Range for YearEnding December 31, 2013Low HighNet Income (Loss) Per Share$ (0.05)$  0.01Stock Compensation Expense0.400.39Amortization of Purchased Intangible Assets0.060.06Non-GAAP Measure of Net Income Per Share$   0.41$  0.46Accessing Cepheid's Fourth Quarter and Full Year 2012 Results Conference CallThe Com
    '/>"/>

    SOURCE Cepheid
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Cepheid to Webcast Upcoming Financial Presentations
    2. Cepheid Announces Executive Vice President Emerging Markets
    3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    10. Luminex Corporation Reports First Quarter 2012 Results
    11. Hospira Reports First-Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
    (Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Insulin ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong ...
    (Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
    Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
    ... 17, 2011 SyntheZyme, a sustainable chemical company founded ... chair and professor of chemical and biological sciences at ... a $475,000 Phase II Small Business Innovation Research ... competitive awards provide federal support for small, highly innovative ...
    ... InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or ... system, today announced that it has filed its Form 10-Q ... U.S. Securities and Exchange Commission. The Company provided an update ... During March and April 2011, InspireMD ...
    Cached Medicine Technology:SyntheZyme Wins Second National Science Foundation Grant to Commercialize Promising Biopesticide 2SyntheZyme Wins Second National Science Foundation Grant to Commercialize Promising Biopesticide 3InspireMD Announces Year-to-Date 2011 Progress 2InspireMD Announces Year-to-Date 2011 Progress 3InspireMD Announces Year-to-Date 2011 Progress 4InspireMD Announces Year-to-Date 2011 Progress 5
    (Date:4/22/2014)... 22 April 2014. The latest scientific advances and emerging ... Failure 2014, the main annual meeting of the Heart ... (ESC). Journalists will also hear breaking news on acute ... Heart Failure, which is part of the main congress. ... Athens, Greece, at the Megaron Athens International Conference Centre ...
    (Date:4/22/2014)... have demonstrated the first size-based form of chromatography ... of living cells. This unique physical approach to ... to whether a cell lives or dies, remains ... through conventional microscopy. , "We,ve developed membrane-embedded nanodot ... both probe and manipulate membrane assemblies, including signaling ...
    (Date:4/22/2014)... exposed to trauma, illness, alcohol or other drug abuse, ... brain cells that can go awry and activate conditions ... of autism. , Until now, it has been unclear ... a developing brain. Past studies have shown that when ... abuse or she experiences some trauma or illness, her ...
    (Date:4/22/2014)... fiction: In enemy territory, activate your cloaking device. And ... to the immune system. Now scientists at Harvard,s Wyss ... tactics to build the first DNA nanodevices that survive ... the way for smart DNA nanorobots that could use ... doctors can today; target drugs to tumors, or even ...
    (Date:4/22/2014)... can help doctors better identify patients who are at ... prevent the often deadly condition, suggest data from a ... Anesthesiology . , Affecting nearly 200,000 Americans a ... failure of the lungs caused by a number of ... infection. High-risk patients can develop ARDS after surgery. ARDS ...
    Breaking Medicine News(10 mins):Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:Life stressors trigger neurological disorders, researchers find 2Health News:Cloaked DNA nanodevices survive pilot mission 2Health News:Cloaked DNA nanodevices survive pilot mission 3Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2
    ... the patients on the national waiting list for kidney ... new organ, no matter how long they are on ... transfusions, these patients have developed antibodies that make it ... ,Researchers at Emory University have developed a decision ...
    ... can significantly improve health and reduce days off work and ... ,The state of housing has a real impact ... and are more likely to be damp - leading to ... our lives inside, little is known about the specific health ...
    ... maker of generic drugs and 19 other companies that ... ,The Food and Drug Administration said the ... halt the marketing of unapproved and potentially dangerous drugs. ... the market, agency officials said. The manufacturers could seek ...
    ... gives red pepper its heat, could inhibit the growth ... ,If the results can be replicated in further ... in the weight management supplements market, currently estimated by ... in 2005 and $3.93bn in the US. ...
    ... increased levels of bioactive compounds in the blood and ... the extracts start// to rival the juice for boosting ... on the rise, particularly in the UK where sales ... coverage of the antioxidant-rich fruit that has commonly been ...
    ... in an online medical training system has caused chaos ... British Medical Association has criticized//his electronic procedure of hiring ... jobless. ,The Medical Training Application Service was ... post of specialist trainee. The deadline for the receipt ...
    Cached Medicine News:Health News:Research Improves Kidney Transplant Chances for Sensitized Patients 2Health News:Research Improves Kidney Transplant Chances for Sensitized Patients 3Health News:Insulating Houses Improves Health and Wellbeing 2Health News:FDA Warns Migraine Medicine Makers 2Health News:Chilli Extract may Stop Fat Cell Growth 2Health News:Science Builds Behind Pomegranate Extracts for Health 2
    ... with the safety and comfort of the practitioner ... called SF-6) leaded glass, the industry standard for ... set for optical clarity, visible light transmission, power ... protecting your eyes, it also helps you look ...
    B-52 Wrap Frame...
    ... lenses and frames are designed with the safety ... lenses are Schott RS-520 (also called SF-6) leaded ... These lenses meet standards, as set for optical ... ,While our eyewear is protecting your eyes, ...
    ... Radiation Protection Goggles ... can be used by ... mm leaded glass, 1.0 ... shields provide increased scatter ...
    Medicine Products: